세포 계수 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Cell Counting Market Summary

The global cell counting market size was estimated at USD 10.2 billion in 2025 and is projected to reach USD 20.5 billion by 2033, growing at a CAGR of 9.3% from 2026 to 2033. As healthcare increasingly pivots towards tailored treatments, precision cell counting methodologies are becoming critical for evaluating cell viability and proliferation rates. In addition, advancements in automated, AI-enabled, and fluorescence-based cell counting systems are improving workflow efficiency and accelerating adoption across research and clinical laboratories.

Market Concentration & Characteristics

The cell counting industry is rapidly evolving with automation, AI-based imaging, and integrated analytical platforms enhancing accuracy and workflow efficiency. Advanced technologies such as spectral flow cytometry and image-based cell counters are replacing manual methods with faster, more reliable analysis. For instance, in May 2025, BD (Becton, Dickinson and Company) launched the FACSDiscover A8 Cell Analyzer, integrating real-time spectral imaging and AI-assisted single-cell analysis for high-resolution applications. AI-driven algorithms are further improving cell recognition and classification accuracy while reducing human error. These innovations are enabling more standardized, scalable, and high-throughput workflows across research and clinical laboratories.

The cell counting industry is witnessing moderate M&A activity, driven by the need to enhance automation, AI-based imaging, and advanced analytical capabilities. Companies are acquiring or partnering with niche players to strengthen their cell analysis, flow cytometry, and high-throughput screening portfolios. These strategic deals are supporting the integration of advanced technologies into cell counting workflows. Overall, M&A activity is enhancing innovation, portfolio expansion, and global competitiveness in the market.

Regulations significantly influence the cell counting market by shaping product standards, validation processes, and clinical adoption. Compliance with GMP, ISO standards, and regulatory guidelines ensures accuracy, reproducibility, and data integrity in cell analysis workflows. Regulatory requirements also govern instrument calibration, quality control, and reliability of automated and AI-based systems. While these frameworks increase development costs and approval timelines, they enhance standardization and user confidence. Overall, regulations support global acceptance and drive quality-focused innovation in cell counting technologies.

Product expansion in the cell counting industry is driven by rising demand for automated, high-throughput, and application-specific solutions in research and diagnostics. Companies are expanding portfolios with AI-enabled cell counters, imaging cytometers, and integrated platforms to improve speed and accuracy. For instance, in May 2026, Thermo Fisher Scientific introduced the Countess Automated Cell Counter, an optics- and image analysis-based system for accurate cell counting and viability assessment using trypan blue staining. Overall, product expansion is enhancing efficiency, scalability, and analytical precision in cell counting solutions.

Regional expansion in the cell counting industry is driven by the rising adoption of cell-based research and clinical diagnostics across emerging and developed regions. Companies are strengthening their presence in Asia-Pacific, Latin America, and the Middle East & Africa through partnerships, distribution networks, and localized operations. Growth is supported by improving laboratory infrastructure and increasing life sciences research investments. Demand for cost-effective, automated cell-counting solutions is further accelerating market penetration. Overall, regional expansion is enhancing the accessibility, adoption, and global market reach of advanced cell counting technologies.

Global Cell Counting Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global cell counting market report on the basis of product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Hemocytometer
  • Automated Cell Counters
  • Microscopes
  • Others
• Consumables & Accessories
  • Reagents
  • Microplates
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Complete Blood Count
  • Automated Cell Counters
  • Manual Cell Counters
• Stem Cell Research
• Cell Based Therapeutics
• Bioprocessing
• Toxicology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Rising Adoption of Automated Cell Counting Technologies
    • 3.3.1.2. Increasing Demand for Cell-Based Research and Drug Discovery
    • 3.3.1.3. Growing Adoption of Flow Cytometry and Image-Based Cell Analysis
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. High Cost of Advanced Cell Counting Systems
    • 3.3.2.2. Complex Regulatory and Quality Compliance
  • 3.3.3. Market Challenges Analysis
  • 3.3.4. Market Opportunity Analysis
• 3.4. Case Study Insights
• 3.5. Business Environment Analysis
  • 3.5.1. PESTLE Analysis
  • 3.5.2. PORTER'S Five Forces Analysis

Chapter 4. Cell Counting Market: Product Business Analysis

• 4.1. Product Market Share, 2025 & 2033
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2021 - 2033 (USD Million)
  • 4.4.2. Spectrophotometers
    • 4.4.2.1. Spectrophotometers Market, 2021 - 2033 (USD Million)
  • 4.4.3. Flow Cytometers
    • 4.4.3.1. Flow Cytometers Market, 2021 - 2033 (USD Million)
  • 4.4.4. Hemocytometer
    • 4.4.4.1. Hemocytometer Market, 2021 - 2033 (USD Million)
  • 4.4.5. Automated Cell Counters
    • 4.4.5.1. Automated Cell Counters Market, 2021 - 2033 (USD Million)
  • 4.4.6. Microscopes
    • 4.4.6.1. Microscopes Market, 2021 - 2033 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others Market, 2021 - 2033 (USD Million)
• 4.5. Consumables & Accessories
  • 4.5.1. Consumables & Accessories Market, 2021 - 2033 (USD Million)
  • 4.5.2. Reagents
    • 4.5.2.1. Reagents Market, 2021 - 2033 (USD Million)
  • 4.5.3. Microplates
    • 4.5.3.1. Microplates Market, 2021 - 2033 (USD Million)
  • 4.5.4. Others (counting beads)
    • 4.5.4.1. Others (counting beads) Market, 2021 - 2033 (USD Million)

Chapter 5. Cell Counting Market: Application Business Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Complete Blood Count
  • 5.4.1. Complete Blood Count Market, 2021 - 2033 (USD Million)
  • 5.4.2. Automated Cell Counters
    • 5.4.2.1. Automated Cell Counters Market, 2021 - 2033 (USD Million)
  • 5.4.3. Manual Cell Counters
    • 5.4.3.1. Manual Cell Counters Market, 2021 - 2033 (USD Million)
• 5.5. Stem Cell Research
  • 5.5.1. Stem Cell Research Market, 2021 - 2033 (USD Million)
• 5.6. Cell Based Therapeutics
  • 5.6.1. Cell Based Therapeutics Market, 2021 - 2033 (USD Million)
• 5.7. Bioprocessing
  • 5.7.1. Bioprocessing Market, 2021 - 2033 (USD Million)
• 5.8. Toxicology
  • 5.8.1. Toxicology Market, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Cell Counting Market: End Use Business Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals & Diagnostic Laboratories
  • 6.4.1. Hospitals & Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
• 6.5. Research & Academic Institutes
  • 6.5.1. Research & Academic Institutes Market, 2021 - 2033 (USD Million)
• 6.6. Pharmaceutical & Biotechnology Companies
  • 6.6.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Cell Counting Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. North America Cell Counting Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Cell Counting Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Cell Counting Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Cell Counting Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Cell Counting Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Cell Counting Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Position Analysis, 2025
• 8.3. Strategy Mapping
• 8.4. Company Profiles/Listing
  • 8.4.1. Thermo Fisher Scientific Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Merck KGaA
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Agilent Technologies, Inc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. PerkinElmer
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. BD
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Danaher Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Bio-Rad Laboratories, Inc.
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. GE HealthCare
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. DeNovix
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives